Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionWoodstock Corp
Latest Disclosed Ownership7,192 shares
Latest Disclosed Value $ 947,474
Woodstock Corp ownership in NBIX / Neurocrine Biosciences, Inc.

On April 8, 2026 - Woodstock Corp filed a 13F-HR form disclosing ownership of 7,192 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $947,474 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 14, 2026 disclosing 7,192 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-08 2026-03-31 13F Neurocrine Biosciences COMMON STOCK 64125C109 7,192 0 0.00 947 -7.16 0.0843
2026-01-14 2025-12-31 13F Neurocrine Biosciences COMMON STOCK 64125C109 7,192 0 0.00 1,020 1.09 0.0875
2025-10-07 2025-09-30 13F Neurocrine Biosciences COMMON STOCK 64125C109 7,192 0 0.00 1,010 11.74 0.0875
2025-07-09 2025-06-30 13F Neurocrine Biosciences COMMON STOCK 64125C109 7,192 -317 -4.22 904 8.80 0.0831
2025-04-09 2025-03-31 13F Neurocrine Biosciences COMMON STOCK 64125C109 7,509 0 0.00 830 -18.95 0.0820
2025-01-15 2024-12-31 13F Neurocrine Biosciences COMMON STOCK 64125C109 7,509 0 0.00 1,025 18.38 0.0987
2024-10-11 2024-09-30 13F Neurocrine Biosciences COMMON STOCK 64125C109 7,509 0 0.00 865 -16.26 0.0833
2024-07-08 2024-06-30 13F Neurocrine Biosciences COMMON STOCK 64125C109 7,509 0 0.00 1,034 -0.19 0.1051
2024-04-09 2024-03-31 13F Neurocrine Biosciences COMMON STOCK 64125C109 7,509 -2,670 -26.23 1,036 -22.82 0.1072
2024-01-08 2023-12-31 13F Neurocrine Biosciences COMMON STOCK 64125C109 10,179 0 0.00 1,341 17.12 0.1553
2023-10-10 2023-09-30 13F Neurocrine Biosciences COMMON STOCK 64125C109 10,179 0 0.00 1,145 19.40 0.1436
2023-07-07 2023-06-30 13F Neurocrine Biosciences COMMON STOCK 64125C109 10,179 0 0.00 960 -6.89 0.1133
2023-04-06 2023-03-31 13F Neurocrine Biosciences COMMON STOCK 64125C109 10,179 0 0.00 1,030 -15.23 0.1314
2023-01-10 2022-12-31 13F Neurocrine Biosciences COMMON STOCK 64125C109 10,179 0 0.00 1,216 12.40 0.1616
2022-10-11 2022-09-30 13F Neurocrine Biosciences COMMON STOCK 64125C109 10,179 0 0.00 1,081 8.97 0.1608
2022-07-11 2022-06-30 13F Neurocrine Biosciences COMMON STOCK 64125C109 10,179 0 0.00 992 3.98 0.1377
2022-04-07 2022-03-31 13F Neurocrine Biosciences COMMON STOCK 64125C109 10,179 -359 -3.41 954 6.24 0.1117
2022-01-07 2021-12-31 13F Neurocrine Biosciences COMMON STOCK 64125C109 10,538 0 0.00 898 -11.18 0.0940
2021-10-05 2021-09-30 13F Neurocrine Biosciences COMMON STOCK 64125C109 10,538 0 0.00 1,011 -1.46 0.1179
2021-07-06 2021-06-30 13F Neurocrine Biosciences COMMON STOCK 64125C109 10,538 0 0.00 1,026 0.10 0.1207
2021-04-05 2021-03-31 13F Neurocrine Biosciences COMMON STOCK 64125C109 10,538 0 0.00 1,025 1.49 0.1303
2021-01-06 2020-12-31 13F Neurocrine Biosciences COMMON STOCK 64125C109 10,538 0 0.00 1,010 -0.30 0.1352
2020-10-02 2020-09-30 13F Neurocrine Biosciences COMMON STOCK 64125C109 10,538 -4,342 -29.18 1,013 -44.19 0.1636
2020-07-07 2020-06-30 13F Neurocrine Biosciences COMMON STOCK 64125C109 14,880 0 0.00 1,815 40.92 0.3094
2020-04-03 2020-03-31 13F Neurocrine Biosciences COMMON STOCK 64125C109 14,880 0 0.00 1,288 -19.45 0.2625
2020-01-13 2019-12-31 13F Neurocrine Biosciences COMMON STOCK 64125C109 14,880 0 0.00 1,599 19.24 0.2604
2019-10-02 2019-09-30 13F Neurocrine Biosciences COMMON STOCK 64125C109 14,880 0 0.00 1,341 6.77 0.2336
2019-07-03 2019-06-30 13F Neurocrine Biosciences COMMON STOCK 64125C109 14,880 0 0.00 1,256 -4.20 0.2193
2019-04-05 2019-03-31 13F Neurocrine Biosciences COMMON STOCK 64125C109 14,880 0 0.00 1,311 23.33 0.2349
2019-01-08 2018-12-31 13F Neurocrine Biosciences COMMON STOCK 64125C109 14,880 0 0.00 1,063 -41.88 0.2133
2018-10-03 2018-09-30 13F Neurocrine Biosciences COMMON STOCK 64125C109 14,880 -1,698 -10.24 1,829 12.28 0.3091
2018-07-23 2018-06-30 13F Neurocrine Biosciences COMMON STOCK 64125C109 16,578 0 0.00 1,629 18.47 0.2999
2018-04-19 2018-03-31 13F Neurocrine Biosciences COMMON STOCK 64125C109 16,578 0 0.00 1,375 6.92 0.2600
2018-01-24 2017-12-31 13F Neurocrine Biosciences COMMON STOCK 64125C109 16,578 0 0.00 1,286 26.57 0.2372
2017-10-06 2017-09-30 13F Neurocrine Biosciences COMMON STOCK 64125C109 16,578 0 0.00 1,016 33.16 0.1937
2017-07-13 2017-06-30 13F Neurocrine Biosciences COMMON STOCK 64125C109 16,578 0 0.00 763 6.27 0.1496
2017-04-05 2017-03-31 13F Neurocrine Biosciences COMMON STOCK 64125C109 16,578 0 0.00 718 11.84 0.1447
2017-01-05 2016-12-31 13F Neurocrine Biosciences COMMON STOCK 64125C109 16,578 -3,381 -16.94 642 -36.50 0.1301
2016-10-06 2016-09-30 13F Neurocrine Biosciences COMMON STOCK 64125C109 19,959 0 0.00 1,011 11.47 0.2069
2016-08-03 2016-06-30 13F Neurocrine Biosciences COMMON STOCK 64125C109 19,959 4 0.02 907 14.96 0.1872
2016-05-10 2016-03-31 13F Neurocrine Biosciences COMMON STOCK 64125C109 19,955 0 0.00 789 -30.12 0.1660
2016-01-11 2015-12-31 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 19,955 0 0.00 1,129 42.19 0.2482
2015-10-16 2015-09-30 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 19,955 0 0.00 794 -16.68 0.1808
2015-07-07 2015-06-30 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 19,955 19,955 953 0.1796
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.